Schnitzler M |
Diabetes mellitus after kidney transplantation in the United States. |
2003 |
Am. J. Transplant. |
pmid:14510709
|
Donners MM et al. |
Low-dose FK506 blocks collar-induced atherosclerotic plaque development and stabilizes plaques in ApoE-/- mice. |
2005 |
Am. J. Transplant. |
pmid:15888024
|
Woodward RS et al. |
Incidence and cost of new onset diabetes mellitus among U.S. wait-listed and transplanted renal allograft recipients. |
2003 |
Am. J. Transplant. |
pmid:12752315
|
Lehmann R et al. |
Successful simultaneous islet-kidney transplantation using a steroid-free immunosuppression: two-year follow-up. |
2004 |
Am. J. Transplant. |
pmid:15196070
|
Lemahieu W et al. |
Cytochrome P450 3A4 and P-glycoprotein activity and assimilation of tacrolimus in transplant patients with persistent diarrhea. |
2005 |
Am. J. Transplant. |
pmid:15888045
|
Axelrod D et al. |
Reduction of CMV disease with steroid-free immunosuppresssion in simultaneous pancreas-kidney transplant recipients. |
2005 |
Am. J. Transplant. |
pmid:15888050
|
Reyes J et al. |
Intestinal transplantation under tacrolimus monotherapy after perioperative lymphoid depletion with rabbit anti-thymocyte globulin (thymoglobulin). |
2005 |
Am. J. Transplant. |
pmid:15888051
|
Knoop C et al. |
Tacrolimus pharmacokinetics and dose monitoring after lung transplantation for cystic fibrosis and other conditions. |
2005 |
Am. J. Transplant. |
pmid:15888057
|
Kandaswamy R et al. |
A prospective randomized trial of steroid-free maintenance regimens in kidney transplant recipients--an interim analysis. |
2005 |
Am. J. Transplant. |
pmid:15888064
|
Djamali A et al. |
Nox2 is a mediator of chronic CsA nephrotoxicity. |
2012 |
Am. J. Transplant. |
pmid:22568654
|
Campbell PM et al. |
Pretransplant HLA antibodies are associated with reduced graft survival after clinical islet transplantation. |
2007 |
Am. J. Transplant. |
pmid:17456201
|
Cavadas PC et al. |
Bilateral trans-humeral arm transplantation: result at 2 years. |
2011 |
Am. J. Transplant. |
pmid:21521475
|
Qazi Y et al. |
Efficacy and Safety of Everolimus Plus Low-Dose Tacrolimus Versus Mycophenolate Mofetil Plus Standard-Dose Tacrolimus in De Novo Renal Transplant Recipients: 12-Month Data. |
2017 |
Am. J. Transplant. |
pmid:27775865
|
English RF et al. |
Long-term comparison of tacrolimus- and cyclosporine-induced nephrotoxicity in pediatric heart-transplant recipients. |
2002 |
Am. J. Transplant. |
pmid:12243498
|
Knechtle SJ |
Guidance for liver transplant immunosuppression. |
2011 |
Am. J. Transplant. |
pmid:21466652
|
Kurtz J et al. |
Lack of role for CsA-sensitive or Fas pathways in the tolerization of CD4 T cells via BMT and anti-CD40L. |
2003 |
Am. J. Transplant. |
pmid:12814472
|
Egli A et al. |
Renal failure five years after lung transplantation due to polyomavirus BK-associated nephropathy. |
2010 |
Am. J. Transplant. |
pmid:20840474
|
Zafrani L et al. |
Incidence, risk factors and clinical consequences of neutropenia following kidney transplantation: a retrospective study. |
2009 |
Am. J. Transplant. |
pmid:19538494
|
Touzot M et al. |
Renal transplantation in HIV-infected patients: the Paris experience. |
2010 |
Am. J. Transplant. |
pmid:20840478
|
Krämer BK et al. |
Tacrolimus once daily (ADVAGRAF) versus twice daily (PROGRAF) in de novo renal transplantation: a randomized phase III study. |
2010 |
Am. J. Transplant. |
pmid:20840480
|
TruneÄka P et al. |
Once-daily prolonged-release tacrolimus (ADVAGRAF) versus twice-daily tacrolimus (PROGRAF) in liver transplantation. |
2010 |
Am. J. Transplant. |
pmid:20840481
|
Budde K et al. |
Novel once-daily extended-release tacrolimus (LCPT) versus twice-daily tacrolimus in de novo kidney transplants: one-year results of Phase III, double-blind, randomized trial. |
2014 |
Am. J. Transplant. |
pmid:25278376
|
Silva HT et al. |
Planned randomized conversion from tacrolimus to sirolimus-based immunosuppressive regimen in de novo kidney transplant recipients. |
2013 |
Am. J. Transplant. |
pmid:24266969
|
Ricciardelli I et al. |
Rapid generation of EBV-specific cytotoxic T lymphocytes resistant to calcineurin inhibitors for adoptive immunotherapy. |
2013 |
Am. J. Transplant. |
pmid:24266973
|
O'Grady JG et al. |
Randomized controlled trial of tacrolimus versus microemulsified cyclosporin (TMC) in liver transplantation: poststudy surveillance to 3 years. |
2007 |
Am. J. Transplant. |
pmid:17109723
|
Böhmig GA et al. |
Immunoadsorption in severe C4d-positive acute kidney allograft rejection: a randomized controlled trial. |
2007 |
Am. J. Transplant. |
pmid:17109725
|
Damon C et al. |
Predictive Modeling of Tacrolimus Dose Requirement Based on High-Throughput Genetic Screening. |
2017 |
Am. J. Transplant. |
pmid:27597269
|
McKenna G and Trotter JF |
Does early (CNI) conversion lead to eternal (renal) salvation? |
2010 |
Am. J. Transplant. |
pmid:20928938
|
Shuker N et al. |
A Randomized Controlled Trial Comparing the Efficacy of Cyp3a5 Genotype-Based With Body-Weight-Based Tacrolimus Dosing After Living Donor Kidney Transplantation. |
2016 |
Am. J. Transplant. |
pmid:26714287
|
Hanto DW et al. |
Intraoperative administration of inhaled carbon monoxide reduces delayed graft function in kidney allografts in Swine. |
2010 |
Am. J. Transplant. |
pmid:20977633
|
Al-Massarani G et al. |
Impact of immunosuppressive treatment on endothelial biomarkers after kidney transplantation. |
2008 |
Am. J. Transplant. |
pmid:18925903
|
Hamdy AF et al. |
Comparison of sirolimus with low-dose tacrolimus versus sirolimus-based calcineurin inhibitor-free regimen in live donor renal transplantation. |
2005 |
Am. J. Transplant. |
pmid:16162204
|
Arnold R et al. |
Association between calcineurin inhibitor treatment and peripheral nerve dysfunction in renal transplant recipients. |
2013 |
Am. J. Transplant. |
pmid:23841745
|
Hirsch HH et al. |
BK Polyomavirus Replication in Renal Tubular Epithelial Cells Is Inhibited by Sirolimus, but Activated by Tacrolimus Through a Pathway Involving FKBP-12. |
2016 |
Am. J. Transplant. |
pmid:26639422
|
Schold JD |
The burden of proof in the design of early phase clinical trials. |
2013 |
Am. J. Transplant. |
pmid:23802723
|
Chisholm-Burns MA et al. |
Improving outcomes of renal transplant recipients with behavioral adherence contracts: a randomized controlled trial. |
2013 |
Am. J. Transplant. |
pmid:23819827
|
Troppmann C et al. |
Impact of portal venous pancreas graft drainage on kidney graft outcome in simultaneous pancreas-kidney recipients reported to UNOS. |
2004 |
Am. J. Transplant. |
pmid:15023146
|
Willicombe M et al. |
Outcome of patients with preformed donor-specific antibodies following alemtuzumab induction and tacrolimus monotherapy. |
2011 |
Am. J. Transplant. |
pmid:21299828
|
Muthusamy AS et al. |
Alemtuzumab induction and steroid-free maintenance immunosuppression in pancreas transplantation. |
2008 |
Am. J. Transplant. |
pmid:18828772
|
Pirenne J et al. |
Tolerance of liver transplant patients to strenuous physical activity in high-altitude. |
2004 |
Am. J. Transplant. |
pmid:15023147
|
Heisel O et al. |
New onset diabetes mellitus in patients receiving calcineurin inhibitors: a systematic review and meta-analysis. |
2004 |
Am. J. Transplant. |
pmid:15023151
|
Srinivas TR et al. |
The noninferiority trial: don't don't do it. |
2010 |
Am. J. Transplant. |
pmid:21087412
|
Bohl DL et al. |
Donor origin of BK virus in renal transplantation and role of HLA C7 in susceptibility to sustained BK viremia. |
2005 |
Am. J. Transplant. |
pmid:16095500
|
Kasahara M et al. |
Living-donor liver transplantation for hepatoblastoma. |
2005 |
Am. J. Transplant. |
pmid:16095502
|
Lemahieu WP et al. |
Combined therapy with atorvastatin and calcineurin inhibitors: no interactions with tacrolimus. |
2005 |
Am. J. Transplant. |
pmid:16095503
|
Meier-Kriesche HU et al. |
Sirolimus in combination with tacrolimus is associated with worse renal allograft survival compared to mycophenolate mofetil combined with tacrolimus. |
2005 |
Am. J. Transplant. |
pmid:16095509
|
Senior PA et al. |
Proteinuria developing after clinical islet transplantation resolves with sirolimus withdrawal and increased tacrolimus dosing. |
2005 |
Am. J. Transplant. |
pmid:16095517
|
RodrÃguez-Perálvarez M et al. |
Tacrolimus exposure after liver transplantation in randomized controlled trials: too much for too long. |
2013 |
Am. J. Transplant. |
pmid:23621166
|
Meier-Kriesche HU and Kaplan B |
Cyclosporine microemulsion and tacrolimus are associated with decreased chronic allograft failure and improved long-term graft survival as compared with sandimmune. |
2002 |
Am. J. Transplant. |
pmid:12095048
|
Vanhove T et al. |
Determinants of the Magnitude of Interaction Between Tacrolimus and Voriconazole/Posaconazole in Solid Organ Recipients. |
2017 |
Am. J. Transplant. |
pmid:28224698
|
Madeleine MM et al. |
HPV-related cancers after solid organ transplantation in the United States. |
2013 |
Am. J. Transplant. |
pmid:24119294
|
Vongwiwatana A et al. |
Peritubular capillary changes and C4d deposits are associated with transplant glomerulopathy but not IgA nephropathy. |
2004 |
Am. J. Transplant. |
pmid:14678043
|
Bressollette-Bodin C et al. |
A prospective longitudinal study of BK virus infection in 104 renal transplant recipients. |
2005 |
Am. J. Transplant. |
pmid:15996241
|
Augustine JJ et al. |
Pre-transplant IFN-gamma ELISPOTs are associated with post-transplant renal function in African American renal transplant recipients. |
2005 |
Am. J. Transplant. |
pmid:15996247
|
Filler G et al. |
Adding sirolimus to tacrolimus-based immunosuppression in pediatric renal transplant recipients reduces tacrolimus exposure. |
2005 |
Am. J. Transplant. |
pmid:15996252
|
Awadalla Y et al. |
HLA mismatching increases the risk of BK virus nephropathy in renal transplant recipients. |
2004 |
Am. J. Transplant. |
pmid:15367226
|
Froud T et al. |
Islet transplantation in type 1 diabetes mellitus using cultured islets and steroid-free immunosuppression: Miami experience. |
2005 |
Am. J. Transplant. |
pmid:15996257
|
Borrows R et al. |
Mycophenolic acid 12-h trough level monitoring in renal transplantation: association with acute rejection and toxicity. |
2006 |
Am. J. Transplant. |
pmid:16433766
|
Shihab F et al. |
Association of Clinical Events With Everolimus Exposure in Kidney Transplant Patients Receiving Low Doses of Tacrolimus. |
2017 |
Am. J. Transplant. |
pmid:28141897
|
Chodoff L and Hamberg KJ |
Response to 'Different preparations of tacrolimus and medication errors'. |
2009 |
Am. J. Transplant. |
pmid:19392982
|
Kohnle M et al. |
Ezetimibe for the treatment of uncontrolled hypercholesterolemia in patients with high-dose statin therapy after renal transplantation. |
2006 |
Am. J. Transplant. |
pmid:16433776
|
Luther P and Baldwin D |
Pioglitazone in the management of diabetes mellitus after transplantation. |
2004 |
Am. J. Transplant. |
pmid:15575920
|
Cherukuri A et al. |
An analysis of lymphocyte phenotype after steroid avoidance with either alemtuzumab or basiliximab induction in renal transplantation. |
2012 |
Am. J. Transplant. |
pmid:22390816
|
Dahm F et al. |
Conversion from cyclosporine to tacrolimus improves quality-of-life indices, renal graft function and cardiovascular risk profile. |
2004 |
Am. J. Transplant. |
pmid:15575921
|
Pascher A et al. |
Protein kinase C inhibitor sotrastaurin in de novo liver transplant recipients: a randomized phase II trial. |
2015 |
Am. J. Transplant. |
pmid:25677074
|
O'Connell PJ et al. |
Multicenter Australian trial of islet transplantation: improving accessibility and outcomes. |
2013 |
Am. J. Transplant. |
pmid:23668890
|
Russ GR et al. |
Efficacy of sotrastaurin plus tacrolimus after de novo kidney transplantation: randomized, phase II trial results. |
2013 |
Am. J. Transplant. |
pmid:23668931
|
Barth RN et al. |
Vascularized bone marrow-based immunosuppression inhibits rejection of vascularized composite allografts in nonhuman primates. |
2011 |
Am. J. Transplant. |
pmid:21668624
|
RodrÃguez-Perálvarez M et al. |
Tacrolimus trough levels, rejection and renal impairment in liver transplantation: a systematic review and meta-analysis. |
2012 |
Am. J. Transplant. |
pmid:22703529
|
Guirado L et al. |
Efficacy and safety of conversion from twice-daily to once-daily tacrolimus in a large cohort of stable kidney transplant recipients. |
2011 |
Am. J. Transplant. |
pmid:21668633
|
Flechner SM et al. |
The ORION study: comparison of two sirolimus-based regimens versus tacrolimus and mycophenolate mofetil in renal allograft recipients. |
2011 |
Am. J. Transplant. |
pmid:21668635
|
Budde K |
How to use mTOR inhibitors? The search goes on. |
2011 |
Am. J. Transplant. |
pmid:21668636
|
Luan FL et al. |
Comparative risk of impaired glucose metabolism associated with cyclosporine versus tacrolimus in the late posttransplant period. |
2008 |
Am. J. Transplant. |
pmid:18786231
|
Chen G et al. |
Anti-CD45RB monoclonal antibody prolongs renal allograft survival in cynomolgus monkeys. |
2007 |
Am. J. Transplant. |
pmid:17227555
|
Woywodt A et al. |
Different preparations of tacrolimus and medication errors. |
2008 |
Am. J. Transplant. |
pmid:18786238
|
Servais A et al. |
Interstitial fibrosis evolution on early sequential screening renal allograft biopsies using quantitative image analysis. |
2011 |
Am. J. Transplant. |
pmid:21672152
|
Senior PA et al. |
Changes in renal function after clinical islet transplantation: four-year observational study. |
2007 |
Am. J. Transplant. |
pmid:17227560
|
Levi Z et al. |
Switching from tacrolimus to sirolimus halts the appearance of new sebaceous neoplasms in Muir-Torre syndrome. |
2007 |
Am. J. Transplant. |
pmid:17229076
|
Ogawa T et al. |
Rho-associated kinase inhibitor reduces tumor recurrence after liver transplantation in a rat hepatoma model. |
2007 |
Am. J. Transplant. |
pmid:17229077
|
Miriuka SG et al. |
mTOR inhibition induces endothelial progenitor cell death. |
2006 |
Am. J. Transplant. |
pmid:16796720
|
Asberg A et al. |
Effects of the intensity of immunosuppressive therapy on outcome of treatment for CMV disease in organ transplant recipients. |
2010 |
Am. J. Transplant. |
pmid:20486914
|
Ryan CM and Swanson DP |
clinical research, innovative practice and IRB review: identifying and respecting boundaries. |
2007 |
Am. J. Transplant. |
pmid:17331113
|
Hautz T et al. |
Molecular markers and targeted therapy of skin rejection in composite tissue allotransplantation. |
2010 |
Am. J. Transplant. |
pmid:20353468
|
Zheng H et al. |
Tacrolimus dosing in pediatric heart transplant patients is related to CYP3A5 and MDR1 gene polymorphisms. |
2003 |
Am. J. Transplant. |
pmid:12694072
|
Montgomery SP et al. |
Efficacy and toxicity of a protocol using sirolimus, tacrolimus and daclizumab in a nonhuman primate renal allotransplant model. |
2002 |
Am. J. Transplant. |
pmid:12118862
|
Ahsan N et al. |
Limited dose monoclonal IL-2R antibody induction protocol after primary kidney transplantation. |
2002 |
Am. J. Transplant. |
pmid:12118902
|
Moench C et al. |
Tacrolimus monotherapy without steroids after liver transplantation--a prospective randomized double-blinded placebo-controlled trial. |
2007 |
Am. J. Transplant. |
pmid:17511685
|
Patlolla V et al. |
Efficacy of anti-IL-2 receptor antibodies compared to no induction and to antilymphocyte antibodies in renal transplantation. |
2007 |
Am. J. Transplant. |
pmid:17564638
|
Nijhoff MF et al. |
Glycemic Stability Through Islet-After-Kidney Transplantation Using an Alemtuzumab-Based Induction Regimen and Long-Term Triple-Maintenance Immunosuppression. |
2016 |
Am. J. Transplant. |
pmid:26288226
|
Lacaille F et al. |
Severe dysimmune cytopenia in children treated with tacrolimus after organ transplantation. |
2006 |
Am. J. Transplant. |
pmid:16611346
|
Chamie K et al. |
The effect of sirolimus on prostate-specific antigen (PSA) levels in male renal transplant recipients without prostate cancer. |
2008 |
Am. J. Transplant. |
pmid:18853950
|
Lefaucheur C et al. |
Renal histopathological lesions after lung transplantation in patients with cystic fibrosis. |
2008 |
Am. J. Transplant. |
pmid:18671673
|
Levy G et al. |
REFINE: a randomized trial comparing cyclosporine A and tacrolimus on fibrosis after liver transplantation for hepatitis C. |
2014 |
Am. J. Transplant. |
pmid:24456049
|
McDonald RA et al. |
Incidence of PTLD in pediatric renal transplant recipients receiving basiliximab, calcineurin inhibitor, sirolimus and steroids. |
2008 |
Am. J. Transplant. |
pmid:18416737
|
Triñanes J et al. |
Deciphering Tacrolimus-Induced Toxicity in Pancreatic β Cells. |
2017 |
Am. J. Transplant. |
pmid:28432716
|
Pradhan M et al. |
Decline in renal function following thoracic organ transplantation in children. |
2002 |
Am. J. Transplant. |
pmid:12201367
|
Ciancio G et al. |
Advantage of rapamycin over mycophenolate mofetil when used with tacrolimus for simultaneous pancreas kidney transplants: randomized, single-center trial at 10 years. |
2012 |
Am. J. Transplant. |
pmid:22946986
|
Pallet N et al. |
Long-Term Clinical Impact of Adaptation of Initial Tacrolimus Dosing to CYP3A5 Genotype. |
2016 |
Am. J. Transplant. |
pmid:26990694
|
Rogers J et al. |
Effect of ethnicity on outcome of simultaneous pancreas and kidney transplantation. |
2003 |
Am. J. Transplant. |
pmid:14510702
|
Chhabra D et al. |
Impact of calcineurin-inhibitor conversion to mTOR inhibitor on renal allograft function in a prednisone-free regimen. |
2013 |
Am. J. Transplant. |
pmid:24007570
|